Literature DB >> 9621103

Activation of human T-cell leukemia virus type 1 tax gene expression in chronically infected T cells.

H C Lin1, C S Dezzutti, R B Lal, A B Rabson.   

Abstract

Expression of human T-cell leukemia virus type 1 (HTLV-1) is regulated both by the HTLV-1 Tax transactivator and by cellular transcriptional factors binding to the viral long terminal repeat (LTR), suggesting that cellular signals may play a role in regulating viral expression. Treatment of cells chronically infected with HTLV-1, which express low levels of HTLV-1 RNAs and Tax protein, with phorbol esters (i.e., phorbol12-myristate 13- acetate [PMA]), phytohemagglutinin (PHA), sodium butyrate, or combinations of cytokines resulted in induction of HTLV- 1 gene expression. PMA or PHA treatment following cotransfection of HTLV-1 Tax expression plasmids resulted in synergistic activation of HTLV-1 LTR-directed gene expression, apparently involving tyrosine ki- nase- mediated pathways. These results suggest that cellular activation stimuli may cooperate with HTLV-1 Tax to enhance expression of integrated HTLV-1 genomes and thus may play a role in the pathogenesis of HTLV-1 disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621103      PMCID: PMC110459     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Transcriptional activation of the human T-lymphotropic virus type I long terminal repeat by functional interaction of Tax1 and Ets1.

Authors:  S D Gitlin; J Dittmer; R C Shin; J N Brady
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

2.  Transcellular activation of the HTLV promoter by human hematopoietic cells.

Authors:  G Baier-Bitterlich; J Rappaport; G Baier; D Looney; F Wong-Staal
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

3.  Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy.

Authors:  E Wattel; J P Vartanian; C Pannetier; S Wain-Hobson
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

4.  HTLV-I messenger RNA is expressed in vivo in adult T-cell leukemia/lymphoma patients: an in situ hybridization study.

Authors:  M Setoyama; T Fujiyoshi; S Mizoguchi; Y Katahira; S Yashiki; M Tara; T Kanzaki; S Sonoda
Journal:  Int J Cancer       Date:  1994-06-01       Impact factor: 7.396

5.  Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor.

Authors:  N M Clark; M J Smith; J M Hilfinger; D M Markovitz
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

6.  Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR.

Authors:  J S Seeler; C Muchardt; M Podar; R B Gaynor
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

7.  The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1.

Authors:  T Suzuki; J I Fujisawa; M Toita; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

8.  Characterization of human T-lymphotropic virus type I- and II-infected T-cell lines: antigenic, phenotypic, and genotypic analysis.

Authors:  C S Dezzutti; D L Rudolph; C R Roberts; R B Lal
Journal:  Virus Res       Date:  1993-07       Impact factor: 3.303

9.  Enhanced human T-cell lymphotropic virus type I expression following induction of the cellular stress response.

Authors:  J M Andrews; M J Oglesbee; A V Trevino; D J Guyot; G C Newbound; M D Lairmore
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

10.  Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP.

Authors:  C Caron; R Rousset; C Béraud; V Moncollin; J M Egly; P Jalinot
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

View more
  9 in total

1.  RNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.

Authors:  Hsin-Ching Lin; Peter J Simon; Riza M Ysla; Steven L Zeichner; Gary Brewer; Arnold B Rabson
Journal:  Virology       Date:  2017-05-04       Impact factor: 3.616

2.  Genetic evidence of a role for ATM in functional interaction between human T-cell leukemia virus type 1 Tax and p53.

Authors:  P L Van; K W Yim; D Y Jin; G Dapolito; A Kurimasa; K T Jeang
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  The region between amino acids 245 and 265 of the bovine leukemia virus (BLV) tax protein restricts transactivation not only via the BLV enhancer but also via other retrovirus enhancers.

Authors:  S Tajima; Y Aida
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Immune activation induces immortalization of HTLV-1 LTR-Tax transgenic CD4+ T cells.

Authors:  Alison Y Swaims; Francesca Khani; Yingyu Zhang; Arthur I Roberts; Satish Devadas; Yufang Shi; Arnold B Rabson
Journal:  Blood       Date:  2010-07-15       Impact factor: 22.113

5.  T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1.

Authors:  Nancy Dumais; Marie-Eve Paré; Simon Mercier; Salim Bounou; Susan J Marriot; Benoit Barbeau; Michel J Tremblay
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Evaluation of HTLV-1 activity in HAM/TSP patients using proviral load and Tax mRNA expression after In Vitro lymphocyte activation.

Authors:  Atefeh Yari; Seyyed Abdolrahim Rezaee; Narges Valizadeh; Taraneh Rajaee; Seyyed Mohammad Jazayeri; Mojdeh Soltani; Mehdi Norouzi
Journal:  Iran J Basic Med Sci       Date:  2014-07       Impact factor: 2.699

7.  Heat Shock Enhances the Expression of the Human T Cell Leukemia Virus Type-I (HTLV-I) Trans-Activator (Tax) Antigen in Human HTLV-I Infected Primary and Cultured T Cells.

Authors:  Marie Kunihiro; Hideki Fujii; Takuya Miyagi; Yoshiaki Takahashi; Reiko Tanaka; Takuya Fukushima; Aftab A Ansari; Yuetsu Tanaka
Journal:  Viruses       Date:  2016-07-11       Impact factor: 5.048

Review 8.  Latency Reversing Agents: Kick and Kill of HTLV-1?

Authors:  Annika P Schnell; Stephan Kohrt; Andrea K Thoma-Kress
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

9.  Characterizing the Interaction between the HTLV-1 Transactivator Tax-1 with Transcription Elongation Factor ELL2 and Its Impact on Viral Transactivation.

Authors:  Stephan Kohrt; Sarah Strobel; Melanie C Mann; Heinrich Sticht; Bernhard Fleckenstein; Andrea K Thoma-Kress
Journal:  Int J Mol Sci       Date:  2021-12-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.